Designer baby

Human germline genome editing

Retrieved on: 
Thursday, February 27, 2020
Branches of biology, Biology, Developmental biology, Life sciences, Genetic engineering, Biotechnology, Germline, Bioethics, Embryo, Emerging technologies, Human germline engineering, Designer baby

POST - Parliamentary Office of Science and Technology

Key Points: 
  • POST - Parliamentary Office of Science and Technology

    Changes made to DNA in human eggs, spermor embryos (germline cells) can be passed on to future generation.

  • The methods used to to make such changes are referred to as human germline genome editing (hGGE).
  • It also outlines current regulation and governance of hGGE and examines issues raised by any potential future uses of hGGE.
  • POST would like to thank interviewees and peer reviewers* for kindly giving up their time during the preparation of this briefing, including:

Global Gene Therapy Technologies, Companies & Markets During the Forecast Period, 2018-2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 9, 2019
Health, Genetics, Branches of biology, Biology, Articles, Emerging technologies, Applied genetics, Biotechnology, Molecular biology, Bioethics, Gene therapy, Therapy, Gene editing, Designer baby

This report takes a broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy reports written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.

Key Points: 
  • This report takes a broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy reports written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.
  • Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.
  • The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy including gene editing and germline gene therapy.
  • The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy markets are estimated for the years 2018-2028.

Global Gene Therapy Research Report 2019: Technologies, Markets & Companies 2018-2028

Retrieved on: 
Monday, August 12, 2019
Branches of biology, Biology, Articles, Emerging technologies, Applied genetics, Biotechnology, Molecular biology, Bioethics, Gene therapy, Therapy, Gene editing, Designer baby

This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.

Key Points: 
  • This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.
  • Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.
  • The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy including gene editing and germline gene therapy.
  • The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy markets are estimated for the years 2018-2028.

Global Gene Therapy Technologies, Markets & Companies Report 2019 with Profiles of 193 Companies, Along with 266 Collaborations - ResearchAndMarkets.com

Retrieved on: 
Monday, August 12, 2019
Health, Genetics, Branches of biology, Biology, Articles, Emerging technologies, Applied genetics, Biotechnology, Molecular biology, Bioethics, Gene therapy, Therapy, Gene editing, Designer baby

This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.

Key Points: 
  • This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.
  • Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.
  • The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy including gene editing and germline gene therapy.
  • The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy markets are estimated for the years 2018-2028.

Casebia Advances Genetic Engineering with New Tools and Techniques

Retrieved on: 
Wednesday, April 24, 2019
Health, Biotechnology, Genetics, Pharmaceutical, Articles, Branches of biology, Life sciences, Biotechnology, Emerging technologies, Molecular biology, Genetic engineering, Gene editing, Medical genetics, Nanoparticle drug delivery, Designer baby

Together, the research outlines a broad suite of new tools and techniques that advance both the methods available to scientists in the gene editing space and Casebias internal therapeutic programs.

Key Points: 
  • Together, the research outlines a broad suite of new tools and techniques that advance both the methods available to scientists in the gene editing space and Casebias internal therapeutic programs.
  • These advances put new tools in the toolbox of our scientists as we work to create life-altering treatments for a variety of genetic diseases.
  • An effective method for delivery of Cas-sRGNs into liver tissue using lipid nanoparticles (LNPs) that potentially enables better treatment of liver-based diseases via genetic engineering.
  • The Casebia technology platform is moving genetic medicine forward by enabling new genetic engineering tools and revolutionary delivery methods for gene editing that target treatments precisely to specific areas of the body affected by disease.

World Cell Therapy Technologies, Ethics, Regulations, Markets, Companies & Academic Institutions 2018-2019 & 2028: Focus on Cardiovascular Disorders, Cancer, & Neurological Disorders

Retrieved on: 
Wednesday, February 27, 2019
Branches of biology, Life sciences, Biology, Biotechnology, Bioethics, Emerging technologies, Genetic engineering, Medical genetics, Therapy, Gene therapy, Embryonic stem cell, Designer baby

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine.

Key Points: 
  • This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine.
  • Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine.
  • Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.
  • Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations.

World Cell Therapy Report 2019: Technologies, Markets and Companies Featuring 300+ Companies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 20, 2019
Health, Biotechnology, Genetics, Pharmaceutical, Articles, Branches of biology, Life sciences, Biotechnology, Emerging technologies, Bioethics, Genetic engineering, Medical genetics, Therapy, Gene therapy, Designer baby, Induced stem cells

The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine.
  • Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine.
  • Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.

Global Gene Therapy Research Report 2019: Technologies, Markets & Companies, 2017-2027 with Analysis of CRISPR-Cas9 and CAR-T Cell Therapies

Retrieved on: 
Monday, February 18, 2019
Biology, Nature, Genetics, Applied genetics, Biotechnology, Bioethics, Genetic engineering, Emerging technologies, Gene therapy, Therapy, Gene editing, Designer baby

This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.

Key Points: 
  • This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.
  • Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.
  • The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy including gene editing and germline gene therapy.
  • The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy markets are estimated for the years 2018-2028.

Gene Therapy: 2019 Technologies, Markets & Companies - Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 4, 2019
Health, Genetics, Branches of biology, Biology, Articles, Emerging technologies, Molecular biology, Applied genetics, Biotechnology, Bioethics, Gene therapy, Gene editing, Therapy, Designer baby

Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.

Key Points: 
  • Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.
  • The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy including gene editing and germline gene therapy.
  • The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy markets are estimated for the years 2018-2028.
  • These companies have been followed up since they were the topic of a book on gene therapy companies by the author of this report.